Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Oct 31, 2025 | (FY)Jul 31, 2025 | (Q4)Jul 31, 2025 | (Q3)Apr 30, 2025 | (Q2)Jan 31, 2025 | (Q1)Oct 31, 2024 | (FY)Jul 31, 2024 | (Q4)Jul 31, 2024 | (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 33.61%439.94M | 2.82%1.69B | 6.72%365.5M | 2.76%533.93M | 8.42%459.51M | -7.50%329.28M | 11.65%1.64B | 8.49%342.47M | 36.48%519.61M | 4.95%423.82M |
| Cost of revenue | 29.48%329.93M | 1.42%1.3B | 5.75%276.04M | 1.55%411.55M | 8.58%359.89M | -10.76%254.82M | 9.61%1.28B | 5.74%261.02M | 37.89%405.26M | 331.44M |
| Gross profit | 47.75%110M | 7.87%385.91M | 9.83%89.46M | 7.02%122.38M | 7.84%99.62M | 5.71%74.45M | 19.64%357.75M | 18.37%81.46M | 31.72%114.35M | 92.38M |
| Operating expense | 21.01%55.02M | 10.74%214.04M | 18.77%54.51M | 6.90%54.48M | 10.64%59.41M | 4.39%45.47M | 5.61%193.28M | -14.25%45.89M | 21.79%50.96M | -85.49%53.69M |
| Selling and administrative expenses | ---- | 10.98%219.25M | ---- | ---- | ---- | ---- | 5.17%197.56M | ---- | ---- | ---- |
| -Selling and marketing expense | ---- | 7.45%80.53M | ---- | ---- | ---- | ---- | 9.46%74.95M | ---- | ---- | ---- |
| -General and administrative expense | ---- | 13.14%138.72M | ---- | ---- | ---- | ---- | 2.71%122.61M | ---- | ---- | ---- |
| Other operating expenses | 17.48%55.55M | 10.48%218.23M | 18.03%55.02M | 6.29%55.13M | 9.74%60.8M | 6.70%47.28M | --197.53M | --46.61M | 23.02%51.87M | -85.10%55.4M |
| Total other operating income | -70.95%527K | 21.59%5.2M | -29.17%510K | -28.45%649K | -18.30%1.4M | 140.26%1.81M | -11.32%4.28M | -65.59%720K | 184.33%907K | 3.83%1.71M |
| Operating profit | 89.68%54.99M | 4.50%171.87M | -1.70%34.96M | 7.11%67.9M | 3.97%40.22M | 7.87%28.99M | 41.79%164.47M | 132.55%35.56M | 40.95%63.39M | 14.78%38.68M |
| Net non-operating interest income (expenses) | -8.16%-1.74M | -0.07%-8.8M | -35.44%-3.53M | 19.85%-1.3M | -4.38%-2.39M | 29.54%-1.61M | -5.63%-8.79M | -22.95%-2.61M | 46.38%-1.62M | -89.31%-2.29M |
| Non-operating interest income | 79.27%147K | 20.47%664.97K | 22.36%197K | 35.79%258K | 16.36%128K | -9.89%82K | 4.14%551.97K | 3.19%161K | 28.38%190K | -10.57%110K |
| Non-operating interest expense | 11.62%1.88M | 1.28%9.46M | 34.68%3.73M | -14.02%1.56M | 4.93%2.51M | -28.79%1.69M | 5.54%9.34M | 21.59%2.77M | -42.89%1.81M | 80.08%2.4M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -7.12%797.23K | -7.11%797K | 79.88%858.35K | 858K | ||||||
| Special income (charges) | 0 | -47.96%32.96K | ||||||||
| Less:Write off | ---- | --0 | ---- | ---- | ---- | ---- | 47.96%-32.96K | ---- | ---- | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 94.46%53.25M | 4.66%163.87M | -4.71%32.22M | 7.82%66.6M | 3.94%37.83M | 11.33%27.38M | 44.69%156.57M | 146.58%33.81M | 47.25%61.77M | 12.01%36.4M |
| Income tax | 125.70%13.64M | 7.86%42.77M | -19.06%9.54M | 34.50%18.99M | 1.03%8.23M | 8.03%6.04M | 33.17%39.65M | 46.68%11.79M | 34.11%14.12M | 19.58%8.15M |
| Net income | 85.61%39.61M | 3.57%121.1M | 2.98%22.68M | -0.09%47.6M | 4.78%29.6M | 12.30%21.34M | 49.06%116.92M | 288.05%22.03M | 51.66%47.65M | 10.00%28.25M |
| Net income continuous operations | 85.61%39.61M | 3.57%121.1M | 2.98%22.68M | -0.09%47.6M | 4.78%29.6M | 12.30%21.34M | 49.06%116.92M | 288.05%22.03M | 51.66%47.65M | 10.00%28.25M |
| Noncontrolling interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to the company | 85.61%39.61M | 3.57%121.1M | 2.98%22.68M | -0.09%47.6M | 4.78%29.6M | 12.30%21.34M | 49.06%116.92M | 288.05%22.03M | 51.66%47.65M | 10.00%28.25M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 85.61%39.61M | 3.57%121.1M | 2.98%22.68M | -0.09%47.6M | 4.78%29.6M | 12.30%21.34M | 49.06%116.92M | 288.05%22.03M | 51.66%47.65M | 10.00%28.25M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 85.58%0.0965 | 3.58%0.2951 | 2.98%0.0553 | -0.09%0.116 | 4.80%0.0721 | 12.31%0.052 | 49.01%0.2849 | 286.33%0.0537 | 51.57%0.1161 | 9.90%0.0688 |
| Diluted earnings per share | 85.58%0.0965 | 3.58%0.2951 | 2.98%0.0553 | -0.09%0.116 | 4.80%0.0721 | 12.31%0.052 | 49.01%0.2849 | 286.33%0.0537 | 51.57%0.1161 | 9.90%0.0688 |
| Dividend per share | 0 | 50.00%0.03 | 0 | 50.00%0.03 | 0 | 0 | -13.04%0.02 | 0 | 53.85%0.02 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.